Skip to main content
Erschienen in: International Journal of Clinical Oncology 5/2018

17.05.2018 | Original Article

Analysis of unexplained carcinoembryonic antigen elevation after curative treatment of locally advanced rectal cancer

verfasst von: Sung Uk Lee, Eunjin Jwa, Dae Yong Kim, Tae Hyun Kim, Ji Yeon Baek, Yongjun Cha, Hee Jin Chang, Jae Hwan Oh

Erschienen in: International Journal of Clinical Oncology | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

To analyze the causes and patterns of unexplained carcinoembryonic antigen (CEA) elevation after curative treatment in locally advanced rectal cancer patients.

Methods

Among the 1309 locally advanced rectal cancer patients treated with curative resection and radiotherapy between January 2001 and June 2011, 325 patients who postoperatively developed abnormal CEA elevation were reviewed. The unexplained CEA elevation was defined as a CEA level higher than 5 ng/mL with no evidence of cancer recurrence at the time of elevation.

Results

Of the 325 patients, 143 (44%) had unexplained CEA elevations. The causes were categorized as delayed recurrence (n = 29, 20%), non-colorectal malignancy (n = 10, 7%), and non-malignancy-related conditions (n = 104, 73%). Shorter intervals between treatment and the first CEA elevation, and a higher peak CEA level, were observed in the delayed recurrence group compared with the non-colorectal malignancy or non-malignancy-related group (intervals of 6.8 vs. 44.9 vs. 23.2 months, respectively, p = 0.002; and peak CEA levels of 9.9 vs. 7.1 vs. 6.2 ng/mL, respectively, p = 0.034). In patients who showed delayed recurrence, the interval between the first CEA elevation and diagnosis of recurrence was a median of 13.0 months (range 3.8–60.6 months). Smoking was the most common cause for non-malignancy-related conditions. The patterns of unexplained CEA elevations were defined as sporadic (n = 78, 55%), stationary (n = 37, 26%), and increasing (n = 28, 20%). The patterns were significantly different depending on the cause (p < 0.001).

Conclusions

Analysis of the patterns of unexplained CEA elevations is a reasonable approach to predict the cause of the cancer.
Literatur
1.
Zurück zum Zitat Gold P, Freedman SO (1965) Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 121(3):439–462CrossRefPubMedPubMedCentral Gold P, Freedman SO (1965) Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 121(3):439–462CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Compton CC, Fielding LP, Burgart LJ et al (2000) Prognostic factors in colorectal cancer: College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124(7):979–994PubMed Compton CC, Fielding LP, Burgart LJ et al (2000) Prognostic factors in colorectal cancer: College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124(7):979–994PubMed
3.
Zurück zum Zitat Park S-H, Kim J-C (2016) Preoperative chemoradiation for locally advanced rectal cancer: comparison of three radiation dose and fractionation schedules. Radiat Oncol J 6(2):96–105 34(CrossRef Park S-H, Kim J-C (2016) Preoperative chemoradiation for locally advanced rectal cancer: comparison of three radiation dose and fractionation schedules. Radiat Oncol J 6(2):96–105 34(CrossRef
4.
Zurück zum Zitat Yoon SM, Kim DY, Kim TH et al (2007) Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 69(4):1167–1172CrossRefPubMed Yoon SM, Kim DY, Kim TH et al (2007) Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 69(4):1167–1172CrossRefPubMed
5.
Zurück zum Zitat Kim YJ, Park SC, Kim DY et al (2012) No correlation between pretreatment serum CEA levels and tumor volume in locally advanced rectal cancer patients. Clin Chim Acta 413(3–4):511–515CrossRefPubMed Kim YJ, Park SC, Kim DY et al (2012) No correlation between pretreatment serum CEA levels and tumor volume in locally advanced rectal cancer patients. Clin Chim Acta 413(3–4):511–515CrossRefPubMed
6.
Zurück zum Zitat Duffy MJ, van Dalen A, Haglund C et al (2007) Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer 43(9):1348–1360CrossRefPubMed Duffy MJ, van Dalen A, Haglund C et al (2007) Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer 43(9):1348–1360CrossRefPubMed
7.
Zurück zum Zitat Litvak A, Cercek A, Segal N et al (2014) False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer. J Natl Compr Cancer Netw 12(6):907–913CrossRef Litvak A, Cercek A, Segal N et al (2014) False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer. J Natl Compr Cancer Netw 12(6):907–913CrossRef
8.
Zurück zum Zitat Greene FLPD., Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M (2002) American Joint Committee on Cancer. Colon and rectum. AJCC cancer staging manual, 6th edn. Springer, New York, pp 113–123CrossRef Greene FLPD., Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M (2002) American Joint Committee on Cancer. Colon and rectum. AJCC cancer staging manual, 6th edn. Springer, New York, pp 113–123CrossRef
9.
Zurück zum Zitat Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen C (1993) An evaluation of the carcinoembryonic antigen (cea) test for monitoring patients with resected colon cancer. JAMA 270(8):943–947CrossRefPubMed Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen C (1993) An evaluation of the carcinoembryonic antigen (cea) test for monitoring patients with resected colon cancer. JAMA 270(8):943–947CrossRefPubMed
10.
Zurück zum Zitat Stevens D, Mackay I, Group BPS (1973) Increased carcinoembryonic antigen in heavy cigarette smokers. The Lancet 302(7840):1238–1239CrossRef Stevens D, Mackay I, Group BPS (1973) Increased carcinoembryonic antigen in heavy cigarette smokers. The Lancet 302(7840):1238–1239CrossRef
11.
Zurück zum Zitat Stockley RA, Shaw J, Whitfield AG, Whitehead TP, Clarke CA, Burnett D (1986) Effect of cigarette smoking, pulmonary inflammation, and lung disease on concentrations of carcinoembryonic antigen in serum and secretions. Thorax 41(1):17–24CrossRefPubMedPubMedCentral Stockley RA, Shaw J, Whitfield AG, Whitehead TP, Clarke CA, Burnett D (1986) Effect of cigarette smoking, pulmonary inflammation, and lung disease on concentrations of carcinoembryonic antigen in serum and secretions. Thorax 41(1):17–24CrossRefPubMedPubMedCentral
12.
13.
Zurück zum Zitat Loewenstein MS, Zamcheck N (1978) Carcinoembryonic antigen (CEA) levels in benign gastrointestinal disease states. Cancer 42(3 Suppl):1412–1418CrossRefPubMed Loewenstein MS, Zamcheck N (1978) Carcinoembryonic antigen (CEA) levels in benign gastrointestinal disease states. Cancer 42(3 Suppl):1412–1418CrossRefPubMed
14.
Zurück zum Zitat Kwon YJ, Lee HS, Shim JY, Lee YJ. Serum carcinoembryonic antigen is positively associated with leukocyte count in Korean adults. J Clin Lab Anal. 2017;e22291CrossRef Kwon YJ, Lee HS, Shim JY, Lee YJ. Serum carcinoembryonic antigen is positively associated with leukocyte count in Korean adults. J Clin Lab Anal. 2017;e22291CrossRef
15.
Zurück zum Zitat No J-I, Yang J-Y, Hyun HJ, Yeon CS, Choi H-J (2013) Factors associated with serum levels of carcinoembryonic antigen in healthy non-smokers. Korean J Fam Med 34(6):413–419CrossRefPubMedPubMedCentral No J-I, Yang J-Y, Hyun HJ, Yeon CS, Choi H-J (2013) Factors associated with serum levels of carcinoembryonic antigen in healthy non-smokers. Korean J Fam Med 34(6):413–419CrossRefPubMedPubMedCentral
Metadaten
Titel
Analysis of unexplained carcinoembryonic antigen elevation after curative treatment of locally advanced rectal cancer
verfasst von
Sung Uk Lee
Eunjin Jwa
Dae Yong Kim
Tae Hyun Kim
Ji Yeon Baek
Yongjun Cha
Hee Jin Chang
Jae Hwan Oh
Publikationsdatum
17.05.2018
Verlag
Springer Japan
Erschienen in
International Journal of Clinical Oncology / Ausgabe 5/2018
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-018-1293-4

Weitere Artikel der Ausgabe 5/2018

International Journal of Clinical Oncology 5/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.